Gene arrays and temporal patterns of drug response: Corticosteroid effects on rat liver

被引:23
作者
Richard R. Almon
Debra C. DuBois
Keri E. Pearson
Dietrich A Stephan
William J. Jusko
机构
[1] Department of Biological Sciences, SUNY at Buffalo, Buffalo, NY 14260
[2] Department of Pharmaceutical Sciences, SUNY at Buffalo, Buffalo, NY 14260
[3] Research Center for Genetic Medicine, Children's National Medical Research Center, Washington
基金
美国国家卫生研究院;
关键词
Cluster analysis; Corticosteroids; Expression profiling; Glucocorticoids;
D O I
10.1007/s10142-003-0090-x
中图分类号
学科分类号
摘要
It was hypothesized that expression profiling using gene arrays can be used to distinguish temporal patterns of changes in gene expression in response to a drug in vivo, and that these patterns can be used to identify groups of genes regulated by common mechanisms. A corticosteroid, methylprednisolone (MPL), was administered intravenously to a group of 47 rats (Rattus rattus) that were sacrificed at 17 timepoints over 72 h after MPL administration. Plasma drug concentrations and hepatic glucocorticoid receptors were measured from each animal. In addition, RNAs prepared from individual livers were used to query Affymetrix genechips for mRNA expression patterns. Statistical analyses using Affymetrix and GeneSpring software were applied to the results. Cluster analysis revealed six major temporal patterns containing 196 corticosteroid-responsive probe sets representing 153 different genes. Four clusters showed increased expression with differences in lag-time, onset rate, and/or duration of transcriptional effect. A fifth cluster showed rapid reduction persisting for 18 h. The final cluster identified showed decreased expression followed by an extended period of increased expression. These results lend new insights into the diverse hepatic genes involved in the physiologic, therapeutic, and adverse effects of corticosteroids and suggest that a limited array of control processes account for the dynamics of their pharmacogenomic effects. © Springer-Verlag 2004.
引用
收藏
页码:171 / 179
页数:8
相关论文
共 26 条
[1]  
Adcock I., Molecular mechanisms of glucocorticosteroid actions, Pulm. Pharmacol. Ther., 13, pp. 115-126, (2000)
[2]  
Almon R., DuBois D.C., Brandenburg E., Shi W., Zhang S., Straubinger R.M., Jusko W.J., Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis, J. Pharmacokin. Pharmacodyn., 29, pp. 103-129, (2002)
[3]  
Baxter J., Advances in glucocorticoid therapy, Adv. Intern. Med., 45, pp. 317-349, (2000)
[4]  
Berdanier C.D., Role of glucocorticoids in the regulation of lipogenesis, FASEB J., 3, pp. 2179-2183, (1989)
[5]  
Bialas M.C., Routledge P.A., Adverse effects of corticosteroids, Adverse Drug React Toxicol. Rev., 17, pp. 227-235, (1998)
[6]  
Burton G., Guan Y., Nagarajan R., McGehee R., Microarray analysis of gene expression during early adipocyte differentiation, Gene, 293, pp. 21-31, (2002)
[7]  
DePrimo S., Diehn M., Nelson J., Reiter R., Matese J., Fero M., Tibshirani R., Brown P., Brooks J., Transcriptional programs activated by exposure of human prostate cancer cells to androgen, Genome Biol., 3, (2002)
[8]  
Ebling W.F., Szefler S.J., Jusko W.J., Methylprednisolone disposition in rabbits: Analysis, prodrug conversion, reversible metabolism and comparison with man, Drug Metab. Dispos., 13, pp. 296-304, (1985)
[9]  
Evans R., The steroid and thyroid hormone superfamily, Science, 240, pp. 889-895, (1988)
[10]  
Frauman A.G., An overview of the adverse reactions to adrenal corticosteroids, Adverse Drug React Toxicol. Rev., 15, pp. 203-206, (1996)